Missed Opportunities for HIV Screening in General Practice
Recruiting · NCT07303114 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Strasbourg, France
View the official record on ClinicalTrials.gov →What this trial is about
The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult subject (≥18 years)
- diagnosed with HIV infection between January 1, 2021, and July 30, 2024
Exclusion criteria
- Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.
Where it is running
1 location listed.
- Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France - Strasbourg, France